Skip to main content
Emergency Medicine Journal : EMJ logoLink to Emergency Medicine Journal : EMJ
. 2002 Jan;19(1):19–22. doi: 10.1136/emj.19.1.19

Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomised controlled trial

M Sanchez 1, B Collvinent 1, O Miro 1, J Horcajada 1, A Moreno 1, F Marco 1, J Mensa 1, J Milla 1
PMCID: PMC1725780  PMID: 11777865

Abstract

Objective: To compare the short-term effectiveness of ceftriaxone single dose followed by cefixime with a standard treatment of acute uncomplicated pyelonephritis in women.

Methods: An open, prospective, and randomised trial of women with acute uncomplicated pyelonephritis was performed. Group A were given a daily intravenous dose of 1 g ceftriaxone; group B: ceftriaxone 1 g intravenous single dose followed by oral cefixime. When urine culture was received, both groups completed a 10 day treatment based in sensitivity studies. Only women with positive initial urine culture were included. After three days of treatment, clinical and bacteriological efficacy was assessed. Clinical response was classified as "cured" if acute symptoms (fever, urinary syndrome and flank pain) were settled. Bacteriological response was classified as: eradication, or no eradication.

Results: Of 144 eligible patients, urine culture was positive in 54 of 72 (75%) women in group A and 51 of 72 (71%) in group B. There were no significant differences between groups in resolution of acute symptoms. Clinical cure was observed in 49 of 54 (91%) patients in the group A and in 47 of 51 (92%) patients in the group B (p = 0.68). After three days of treatment urine culture was negative for all patients. No adverse effects were observed in either of the groups.

Conclusion: These data suggest that a intravenous single dose of ceftriaxone followed by oral cefixime is both effective and safe for the initial treatment of acute uncomplicated pyelonephritis in women. This regimen could be useful in managing selected patients with pyelonephritis as outpatients.

Full Text

The Full Text of this article is available as a PDF (88.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Angel J. L., O'Brien W. F., Finan M. A., Morales W. J., Lake M., Knuppel R. A. Acute pyelonephritis in pregnancy: a prospective study of oral versus intravenous antibiotic therapy. Obstet Gynecol. 1990 Jul;76(1):28–32. [PubMed] [Google Scholar]
  2. Gupta K., Scholes D., Stamm W. E. Increasing prevalence of antimicrobial resistance among uropathogens causing acute uncomplicated cystitis in women. JAMA. 1999 Feb 24;281(8):736–738. doi: 10.1001/jama.281.8.736. [DOI] [PubMed] [Google Scholar]
  3. Hooton T. M., Stamm W. E. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am. 1997 Sep;11(3):551–581. doi: 10.1016/s0891-5520(05)70373-1. [DOI] [PubMed] [Google Scholar]
  4. Millar L. K., Wing D. A., Paul R. H., Grimes D. A. Outpatient treatment of pyelonephritis in pregnancy: a randomized controlled trial. Obstet Gynecol. 1995 Oct;86(4 Pt 1):560–564. doi: 10.1016/0029-7844(95)00244-l. [DOI] [PubMed] [Google Scholar]
  5. doi: 10.1098/rspb.1998.0455. [DOI] [PMC free article] [Google Scholar]
  6. Rodman D. P., McKnight J. T., Anderson R. L. A critical review of the new oral cephalosporins. Considerations and place in therapy. Arch Fam Med. 1994 Nov;3(11):975–980. doi: 10.1001/archfami.3.11.975. [DOI] [PubMed] [Google Scholar]
  7. Safrin S., Siegel D., Black D. Pyelonephritis in adult women: inpatient versus outpatient therapy. Am J Med. 1988 Dec;85(6):793–798. doi: 10.1016/s0002-9343(88)80023-8. [DOI] [PubMed] [Google Scholar]
  8. Sandberg T., Alestig K., Eilard T., Ek E., Hebelka M., Johansson E., Olinder-Nielsen A. M. Aminoglycosides do not improve the efficacy of cephalosporins for treatment of acute pyelonephritis in women. Scand J Infect Dis. 1997;29(2):175–179. doi: 10.3109/00365549709035880. [DOI] [PubMed] [Google Scholar]
  9. Smith C. R., Ambinder R., Lipsky J. J., Petty B. G., Israel E., Levitt R., Mellits E. D., Rocco L., Longstreth J., Lietman P. S. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial. Ann Intern Med. 1984 Oct;101(4):469–477. doi: 10.7326/0003-4819-101-4-469. [DOI] [PubMed] [Google Scholar]
  10. Stamm W. E., Hooton T. M., Johnson J. R., Johnson C., Stapleton A., Roberts P. L., Moseley S. L., Fihn S. D. Urinary tract infections: from pathogenesis to treatment. J Infect Dis. 1989 Mar;159(3):400–406. doi: 10.1093/infdis/159.3.400. [DOI] [PubMed] [Google Scholar]
  11. Talan D. A., Stamm W. E., Hooton T. M., Moran G. J., Burke T., Iravani A., Reuning-Scherer J., Church D. A. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial. JAMA. 2000 Mar 22;283(12):1583–1590. doi: 10.1001/jama.283.12.1583. [DOI] [PubMed] [Google Scholar]
  12. Ward G., Jorden R. C., Severance H. W. Treatment of pyelonephritis in an observation unit. Ann Emerg Med. 1991 Mar;20(3):258–261. doi: 10.1016/s0196-0644(05)80935-7. [DOI] [PubMed] [Google Scholar]

Articles from Emergency Medicine Journal : EMJ are provided here courtesy of BMJ Publishing Group

RESOURCES